9540 Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Amphetamine ............... 1100 II 

Methamphetamine ........ 1105 II 

The company plans to use the listed 

controlled substances to develop 

manufacturing processes, and conduct 

analytical and stability testing. The 

company has demonstrated and 

received patent numbers U.S. 9,278,904 

and U.S. 9,321,794 from the U.S. Patent 

Office for the synthesis process for 

amphetamines. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–02973 Filed 2–12–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–783] 

Importer of Controlled Substances 

Application: Siegfried USA, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Siegfried USA, LLC has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 18, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

March 18, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 6, 2021, 

Siegfried USA, LLC, 33 Industrial Park 

Road, Pennsville, New Jersey 08070, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug 

code Schedule 

Phenylacetone .............. 8501 II 

Opium, Raw .................. 9600 II 

Poppy Straw Concentrate.9670 II 

The company plans to import the 

listed controlled substances to 

manufacture bulk active pharmaceutical 

ingredients (API) for distribution to its 

customers. Phenylacetone will be used 

to manufacture Amphetamine. No other 

activity for this drug code is authorized 

for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–02974 Filed 2–12–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

National Institute of Corrections 

Advisory Board; Notice of Meeting 

This notice announces a forthcoming 

meeting of the National Institute of 

Corrections (NIC) Advisory Board. At 

least one portion of the meeting will be 

closed to the public. 

Name of the Committee: NIC 

Advisory Board. 

General Function of the Committee: 

To aid the National Institute of 

Corrections in developing long-range 

plans, advise on program development, 

and recommend guidance to assist NIC’s 

efforts in the areas of training, technical 

assistance, information services, and 

policy/program development assistance 

to Federal, state, and local corrections 

agencies. 

Date and Time: 1:00–4:00 p.m. EDT 

on Wednesday, March 10, 2021 

(approximate time). 

Location: Virtual Platform. 

Contact Person: Leslie LeMaster, 

Executive Assistant, National Institute 

of Corrections, 320 First Street NW, 

Room 901–3, Washington, DC 20534. To 

contact Ms. LeMaster, please call (303) 

338–6620. 

Agenda: On March 10, 2021, the 

Advisory Board will: (1) Receive a brief 

Agency Report from the NIC Acting 

Director, (2) provide input and counsel 

into an agency decision regarding access 

to online training courses hosted by 

NIC, and (3) receive a Subcommittee 

Report related to the identification of 

potential NIC Director candidates. Time 

for questions and counsel is built in to 

the agenda. 

Procedure: On March 10, 2021, from 

1:00 p.m. until 3:00 p.m., the meeting is 

open to the public. Interested persons 

may request to attend virtually, present 

data, information, or views, orally or in 

writing, on issues pending before the 

committee. Such requests must be made 

to the contact person on or before 

February 26, 2021. Oral presentations 

from the public will be scheduled 

between approximately 2:45 p.m. to 

3:00 p.m. on March 10, 2021. Time 

allotted for each presentation may be 

limited. Those who wish to make formal 

oral presentations should notify the 

contact person and submit a brief 

statement of the general nature of the 

evidence or arguments they wish to 

present, the names and addresses of 

proposed participants, and an 

indication of the approximate time 

requested to make their presentation on 

or before February 26, 2021. 

Closed Committee Deliberations: On 

March 10, 2021, between 3:00 p.m. and 

4:00 p.m., the meeting will be closed to 

permit discussion of information that (1) 

relates solely to the internal personnel 

rules and practices of an agency (5 

U.S.C. 552b(c)(2)), and (2) is of a 

personal nature where disclosure would 

constitute a clearly unwarranted 

invasion of personal privacy (5 U.S.C. 

552b(c)(6)). The Advisory Board will 

discuss the outcomes of the 

subcommittee’s review of potential 

candidates for the position of Director of 

the National Institute of Corrections and 

make determinations as to the Advisory 

Board’s recommendations to the U.S. 

Attorney General. 

General Information: NIC welcomes 

the attendance of the public at its 

advisory committee meetings and will 

make every effort to accommodate 

persons with physical disabilities or 

special needs. If you require special 

accommodations due to a disability, 

please contact Leslie LeMaster at least 7 

days in advance of the meeting. Notice 

of this meeting is given under the 


khammond on DSKJM1Z7X2PROD with NOTICES